Hiroshi Fujiwara, MD, PhD¹, Takashi Ishida, MD, PhD^2*, Kisato Nosaka, MD. PhD³, Naoya Taira, MD^4*, Yasunobu Abe, MD, PhD^5*, Yoshitaka Imaizumi, MD, PhD^6*, Yukiyoshi Moriuchi, MD^7*, Tatsuro Jo, MD, PhD⁸, Kenichi Ishizawa, M.D., Ph.D.^9*, Kensei Tobinai, MD, PhD¹⁰, Kunihiro Tsukasaki, MD, PhD¹¹, Shigeki Ito, MD, PhD¹², Makoto Yoshimitsu¹³, Maki Otsuka^14*, Michinori Ogura, MD^15,16*, Shuichi Midorikawa, PhD^17*, Wanda Ruiz, PhD^17* and Tomoko Ohtsu, MD¹⁷

¹First Department of Internal Medicine, Ehime University Hospital, Ehime, Japan
²Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
³Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan
⁴Department of Hematology, Heart Life Hospital, Okinawa, Japan
⁵Department of Hematology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
⁶Department of Hematology, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan
⁷Department of Hematology, Sasebo City General Hospital, Sasebo, Japan
⁸Department of Hematology, Japanese Red Cross Nagasaki Genbaku Hospital, Nagasaki, Japan
⁹Department of Hematology and Rheumatology, Tohoku University Hospital, Sendai, Japan
¹⁰National Cancer Center Hospital, Tokyo, Japan
¹¹Department of Hematology, National Cancer Center Hospital East, Chiba, Japan
¹²Department of Hematology and Oncology, Iwate Medical University, Morioka, Japan
¹³Department of Hematology and Immunology, Kagoshima University Hospital, Kagoshima, Japan
¹⁴Department of Hematology, National Hospital Organization Kagoshima Medical Center, Kagoshima, Japan
¹⁵Department of Hematology, Tokai Central Hospital, Kakamigahara, Japan
¹⁶Department of Hematology and Oncology, Nagoya Daini Red Cross Hospital, Nagoya, Japan
¹⁷Celgene K.K., Tokyo, Japan

Craig H Moskowitz¹, Michelle A Fanale², Bijal D Shah³, Ranjana H Advani, MD⁴, Robert Chen⁵, Stella Kim^6*, Ana Kostic^7*, Tina Liu^7*, Joanna Peng^7* and Andres Forero-Torres⁸

¹Memorial Sloan Kettering Cancer Center, New York, NY
²University of Texas M.D. Anderson Cancer Center, Houston, TX
³H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
⁴Stanford University Medical Center, Stanford, CA
⁵City of Hope National Medical Center, Duarte, CA
⁶Cizik Eye Clinic, Houston, TX
⁷Seattle Genetics, Inc., Bothell, WA
⁸University of Alabama at Birmingham, Birmingham, AL

Stephen J. Schuster, MD¹, Jakub Svoboda, MD¹, Sunita Dwivedy Nasta, MD¹, David L. Porter, MD¹, Elise A. Chong, MD¹, Daniel J. Landsburg, MD¹, Anthony R. Mato, MD, MSCE¹, Simon F. Lacey, PhD, BS^2*, Jan J. Melenhorst, PhD^3*, Anne Chew, PhD^3*, Jens Hasskarl, MD, PhD^4*, Gaurav D. Shah, MD^5*, Mariusz A. Wasik, MD^6*, Katherine T. Marcucci, PhD^3*, Zhaohui Zheng, MS^2*, Bruce L. Levine, PhD³ and Carl H. June, MD³

¹Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
²Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA
³Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA
⁴Novartis, Basel, Switzerland
⁵Novartis, East Hanover, NJ
⁶Pathology and Laboratory Medicine, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA

Cameron J Turtle, MBBS, PhD^1,2, Carolina Berger, MD^1,2, Daniel Sommermeyer, PhD^1*, Laila-Aicha Hanafi, PhD^1*, Barbara Pender, MS^1*, Emily M Robinson, BS^1*, Katherine Melville^1*, Tanya M Budiarto, BSc^1*, Natalia N Steevens^1*, Colette Chaney, RN^1*, Sindhu Cherian, MD³, Brent L Wood, MD, PhD^1,3, Lorinda Soma, MD^3*, Xueyan Chen, MD, PhD,^3*, Shelly Heimfeld, PhD¹, Michael C Jensen, MD^1,4,5*, Stanley R. Riddell, MD^1,2* and David G Maloney, MD, PhD^1,6

¹Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
²Department of Medicine, University of Washington, Seattle, WA
³Department of Laboratory Medicine, University of Washington, Seattle, WA
⁴Department of Pediatrics, University of Washington, Seattle, WA
⁵Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute, Seattle, WA
⁶Division of Medical Oncology, University of Washington, Seattle, WA

Carlos A. Ramos, MD¹, Brandon Ballard, BS^1*, Enli Liu, MD, MS^1*, Olga Dakhova, PhD^1*, Zhuyong Mei, MD^1*, Hao Liu, PhD^2*, Bambi Grilley, RPh^1*, Cliona M. Rooney, PhD^3*, Adrian P. Gee, PhD¹, Bill H. Chang, MD, PhD⁴, Catherine M. Bollard, MD¹, Malcolm K. Brenner, MD, PhD³, Gianpietro Dotti, MD^3*, Helen E. Heslop, MD³ and Barbara Savoldo, MD, PhD^1*

¹Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital, and Texas Children's Hospital, Houston, TX
²Dan L. Duncan Cancer Center/Biostatistics, Baylor College of Medicine, Houston, TX
³Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX
⁴Oregon Health & Science University Knight Cancer Institute, Portland, OR

Ann Leen, PhD¹, Ifigeneia Tzannou, MD^1*, Munu Bilgi^1*, Hao Liu, PhD^1*, Juan F Vera, MD^1*, Ulrike Gerdemann, MD^2*, Rammurti T Kamble, MD¹, Carlos A. Ramos, MD¹, Bambi Grilley, RPh^3*, Adrian P. Gee, PhD³, Catherine M. Bollard, MD^4,5, Malcolm K. Brenner, MD, PhD¹, Helen E. Heslop, MD¹, Cliona M. Rooney, PhD^1* and George Carrum, MD¹

¹Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX
²Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital, Houston, TX
³Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital, and Texas Children's Hospital, Houston, TX
⁴Children's National Hospital, Washington, DC
⁵The George Washington University, Washington, DC